Oppilotech have developed a unique high-resolution platform based on systems biology and machine learning to model biological processes in cells. The platform is utilized to identify first-in-class viable drug targets and to develop novel modes of action drugs modulating the identified targets. Three first-in-class antibacterial drug targets and generated active chemical matter against 2 of them.
| Status | Active |
| Website | http://oppilotech.com/ |
| Category | AI & Biotech |
| Modality | Small Molecule |
| Headquarters | London, UK |
| Partner | Innovate UK Babraham Accelrator Francis Crick Institute |
| Investment Portfolio | Pre-Fund Investment |